Purity and neurotoxin content are central to a favourable safety profile.
AxeniQ pairs a high-purity formulation with a low neurotoxin load per vial —
helping to minimise the risk of adverse events while delivering reliable results.
SEC-HPLC Purity
Criteria ≥ 95%
Toxin Complex
Confirmed by SDS-PAGE
Neurotoxin Per Vial
Low load
High-purity Neurotoxin
Clostridium botulinum
Compared with conventional freeze-drying, vacuum drying avoids the ice-nucleation step
that can denature protein — preserving potency, purity and structural integrity
from the very first stage of manufacturing.
AxeniQ
AxeniQ
Botulinum toxin type A with a low neurotoxin load per vial and a clean impurity profile.
Consistent, stable structure
Intact high-molecular-weight complex protects core neurotoxin until administration.
Potency held within specification across a 36-month shelf life at 2–8 °C.
Visible smoothing within days; typical effect duration of 3–4 months for glabellar lines.
100 U and 200 U formats for focused or multi-area treatment.
Botulinum toxin type A with a low neurotoxin load per vial and a clean impurity profile.
A single dominant peak on SEC-HPLC, with an average purity of 99.59% — well above the 95% regulatory criterion.
Impurities that are not part of the toxin are removed, so each unit delivered is the unit intended.
Visible smoothing within days of treatment, with a predictable path to full effect.
A firm, uniform cake dissolves evenly — no waiting, no agitation.
Precise action on the treatment area, with spread that stays where it is placed.
Consistent concentration at 4 U / 0.1 mL supports reproducible placement.
Temporary reduction of muscle activity for the improvement of moderate to severe facial wrinkles.
One toxin covers focused and multi-area sessions without switching product.
Typical effect duration of 3-4 months for glabellar lines, with potency held within specification for 36 months in the vial.
Predictable duration makes follow-up scheduling straightforward.
Four measured properties that work together to support a favourable safety profile.
Every claim on this page traces back to a released analytical specification.
A single dominant peak on SEC-HPLC, with an average purity of 99.59% — well above the 95% regulatory criterion.
Impurities that are not part of the toxin are removed, so each unit delivered is the unit intended.
Visible smoothing within days of treatment, with a predictable path to full effect.
A firm, uniform cake dissolves evenly — no waiting, no agitation.
Precise action on the treatment area, with spread that stays where it is placed.
Consistent concentration at 4 U / 0.1 mL supports reproducible placement.
Temporary reduction of muscle activity for the improvement of moderate to severe facial wrinkles.
One toxin covers focused and multi-area sessions without switching product.
Typical effect duration of 3-4 months for glabellar lines, with potency held within specification for 36 months in the vial.
Predictable duration makes follow-up scheduling straightforward.
Four measured properties that work together to support a favourable safety profile.
Every claim on this page traces back to a released analytical specification.
The molecular weight of the protein subunits composing the botulinum toxin type A complex was confirmed by SDS-PAGE, verifying the expected profile of the 900 kDa complex (19S).
Both vials contain the same vacuum-dried botulinum toxin type A.
The choice depends on the number and size of the muscles treated in a single session.
Dilute with preservative-free sterile 0.9% saline. Both formats reconstitute to a working concentration of 4 U / 0.1 mL: the 100 U vial to 2.5 mL, the 200 U vial to 5.0 mL. For intramuscular use only. Single dose per vial — discard any unused portion. Refer to the approved package insert.
White to pale-yellow vacuum-dried powder in a single-dose vial; a clear, particle-free solution when reconstituted. Refrigerate at 2–8 °C and protect from light. Shelf life 36 months from manufacturing date.
AxeniQ temporarily reduces muscle activity for the improvement of facial wrinkles. The 100 U vial covers the core upper-face areas; the 200 U vial extends to larger muscles and multi-area sessions.
Core indication — improves frown lines between the brows.
For Partnership inquiries and to explore how we can work together.
We use cookies to enhance your experience. You can accept all, reject non-essential, or customize your choices.
Cookie settings
Required for site function (security, session, forms).
Remember your choices like language or layout.
